In a fast-changing Nordic CRO industry, CTC Clinical Trial Consultants has opted to differentiate with a unique one-stop-shop approach. CEO Anders Millerhovf reveals how the relatively young company has managed to take over the Swedish scene. Moreover, he outlines the challenges faced by early clinical development and discusses the strategies CTC has established to deal with these challenges.
Many people in the industry were worried about what would happen if all phase I studies disappeared from Sweden, and in retrospect, I have realized how fundamentally important it was to keep clinical trial expertise within the country
